205. Fragile X syndrome related disease
3 clinical trials, 3 drugs (DrugBank: 2 drugs), 21 drug target genes, 25 drug target pathways
Searched query = "Fragile X syndrome related disease", "Fragile X-associated tremor/ataxia syndrome", "FXTAS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02197104 (ClinicalTrials.gov) | January 2015 | 14/7/2014 | Citocoline for Treatment of FXTAS | Phase 2 Study of Citocoline for Treatment in Fragile X-associated Tremor/Ataxia Syndrome | Balance and Cognitive Deficits in Fragile X-associated Tremor Ataxia Syndrome | Drug: citocoline | Rush University Medical Center | NULL | Completed | 18 Years | 90 Years | All | 10 | Phase 2 | United States |